The Evolving Treatment Paradigm of Multiple Myeloma: Insights from Experts at the Cleveland Clinic

Experts from the Cleveland Clinic provide an overview of recent updates in the treatment landscape for patients with multiple myeloma, discussing patient cases, clinical trials, and improving outcomes for patients.

Centering discussion on a patient case of transplant-eligible newly diagnosed multiple myeloma, expert panelists consider optimal workup and management strategies.

A focused discussion on navigating the treatment armamentarium for patients with transplant-eligible newly diagnosed multiple myeloma.

Panelists move on to review a patient case of transplant-ineligible newly diagnosed multiple myeloma and highlight clinical workup strategies.

Expert perspectives on selection of induction therapy for patients with transplant-ineligible newly diagnosed multiple myeloma.

Expert panelists center discussion on a final patient case to review the identification and management of relapsed/refractory multiple myeloma.

A review of novel treatment modalities for relapsed/refractory multiple myeloma, with a focus on selecting and sequencing bispecific antibodies and CAR T-cell therapies.

Before closing out their discussion on multiple myeloma management, panelists reflect on real-world clinical practice perspectives on treatment with bispecifics.